Consistent with our observations, previous work has shown that Podoplanin-expressing myofibroblasts (corresponding to ECM-myCAF and IFNαβ-myCAF) are enriched at the interface with cancer cells where non-activated fibroblasts and EC were depleted80. This evidence concerns the gene PDPN and cancer.